KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) EPS (Basic) (2016 - 2025)

Amgen (AMGN) has 17 years of EPS (Basic) data on record, last reported at $2.47 in Q4 2025.

  • For Q4 2025, EPS (Basic) rose 111.11% year-over-year to $2.47; the TTM value through Dec 2025 reached $14.33, up 88.06%, while the annual FY2025 figure was $14.33, 88.06% up from the prior year.
  • EPS (Basic) reached $2.47 in Q4 2025 per AMGN's latest filing, down from $5.98 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $5.98 in Q3 2025 and bottomed at -$0.21 in Q1 2024.
  • Average EPS (Basic) over 5 years is $2.85, with a median of $2.77 recorded in 2021.
  • Peak YoY movement for EPS (Basic): crashed 103.95% in 2024, then soared 1633.33% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at $3.36 in 2021, then dropped by 10.12% to $3.02 in 2022, then tumbled by 52.32% to $1.44 in 2023, then fell by 18.75% to $1.17 in 2024, then soared by 111.11% to $2.47 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were $2.47 in Q4 2025, $5.98 in Q3 2025, and $2.66 in Q2 2025.